FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer

FDA: approves Pfizer's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories